MSP Recovery Price to Book Ratio 2020-2024 | MSPR

Historical price to book ratio values for MSP Recovery (MSPR) over the last 10 years. The current price to book ratio for MSP Recovery as of April 30, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

MSP Recovery Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-04-30 2.02 0.01
2024-09-30 0.15 $136.57 0.00
2024-06-30 0.46 $181.15 0.00
2024-03-31 0.69 $222.52 0.00
2023-12-31 2.27 $255.62 0.01
2023-09-30 5.37 $297.63 0.02
2023-06-30 8.20 $348.02 0.02
2023-03-31 21.25 $390.33 0.05
2022-12-31 40.00 $423.86 0.09
2022-09-30 30.00 $1,046.10 0.03
2022-06-30 53.50 $1,051.14 0.05
2022-03-31 256.50 $-1,966.28 -0.13
2021-12-31 249.00 0.00
2021-09-30 247.75 $-2,024.89 -0.12
2021-06-30 246.75 $345.46 0.71
2021-03-31 245.50 $364.26 0.67
2020-12-31 252.00 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.016B $0.018B
MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.687B 52.05
Tempus AI (TEM) United States $9.349B 0.00
Hims & Hers Health (HIMS) United States $7.785B 125.14
Inspire Medical Systems (INSP) United States $4.759B 92.44
IRhythm Technologies (IRTC) United States $3.404B 0.00
Privia Health (PRVA) United States $2.840B 212.82
Enovis (ENOV) United States $1.994B 12.34
Schrodinger (SDGR) United States $1.883B 0.00
Clover Health Investments (CLOV) United States $1.763B 0.00
Omnicell (OMCL) United States $1.471B 31.72
Phreesia (PHR) United States $1.461B 0.00
Azenta (AZTA) United States $1.216B 56.62
10x Genomics (TXG) United States $1.025B 0.00
Butterfly Network (BFLY) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.560B 0.00
Talkspace (TALK) United States $0.532B 316.00
Veradigm (MDRX) United States $0.457B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.389B 0.00
Claritev (CTEV) United States $0.373B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Pulmonx (LUNG) United States $0.212B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.211B 0.00
Nyxoah SA (NYXH) Belgium $0.204B 0.00
American Well (AMWL) United States $0.114B 0.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.082B 0.00
CareCloud (CCLD) United States $0.077B 3.31
111 (YI) China $0.072B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.041B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00